Cogent Biosciences Inc (NASDAQ: COGT) on Friday, soared 2.23% from the previous trading day, before settling in for the closing price of $11.64. Within the past 52 weeks, COGT’s price has moved between $3.67 and $12.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -6.78% over the last five years. The company achieved an average annual earnings per share of 4.11%. With a float of $86.06 million, this company’s outstanding shares have now reached $86.12 million.
The firm has a total of 164 workers. Let’s measure their productivity. In terms of profitability, gross margin is 32.09%, operating margin of -4377.22%, and the pretax margin is -4063.08%.
Cogent Biosciences Inc (COGT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cogent Biosciences Inc is 21.37%, while institutional ownership is 90.08%.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.64 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.5) by -0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.11% per share during the next fiscal year.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Cogent Biosciences Inc (COGT) is currently performing well based on its current performance indicators. A quick ratio of 9.25 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -2.30 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 1.04 million was lower than the volume posted last year of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 79.75%. Additionally, its Average True Range was 0.54.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 95.38%, which indicates a significant decrease from 97.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.17% in the past 14 days, which was lower than the 55.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.52, while its 200-day Moving Average is $8.11. Now, the first resistance to watch is $12.11. This is followed by the second major resistance level at $12.31. The third major resistance level sits at $12.69. If the price goes on to break the first support level at $11.53, it is likely to go to the next support level at $11.15. Should the price break the second support level, the third support level stands at $10.95.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
Market capitalization of the company is 1.30 billion based on 95,613K outstanding shares. Right now, sales total 0 K and income totals -192,410 K. The company made 0 K in profit during its latest quarter, and -58,950 K in sales during its previous quarter.
